Micro-Cap Pharma Moving Ahead with Plans for Phase 3 US Trial of a Repurposed Drug for Covid-19
Source: Streetwise Reports  (6/3/20)
Revive Therapeutics is focused on infectious diseases as well as treatments using psilocybin-based formulations. More >

Telemedicine Firm Achieves Record Revenue in Q1/20
Source: Streetwise Reports  (6/3/20)
Also during the quarter, CloudMD Software & Services completes an acquisition, releases an app and upgrades its stock listing. More >

COVID-19: A Catalyst for Small-Cap Outperformance
Source: Steve Palmer for Streetwise Reports  (6/3/20)
Steve Palmer, president and chief investment officer of AlphaNorth Asset Management, outlines why he believes Canadian companies on the TSX Venture Index remain good investments in a time of pandemic uncertainty. More >

Immunotherapy Firm Releases Data Showing Treatment Potential Against Sepsis
Source: Streetwise Reports  (6/3/20)
Recently presented results from Enlivex Therapeutics' Phase 1b study in sepsis and their implications are reviewed in an H.C. Wainwright & Co. report. More >

AI Firm Receives Grant to Create Deep Learning Tools to Enhance Organ Donation Processes
Source: Streetwise Reports  (6/3/20)
Xtract AI has secured a CA$150,000 grant from the Innovative Solutions Canada program to utilize artificial intelligence to increase organ donations and improve transplant success rates. More >

Cassava Shares Rise on Updated Phase 2b Alzheimer's Drug Trial Data
Source: Streetwise Reports  (6/3/20)
Shares of Cassava Sciences traded 70% higher after the firm provided updates from its Phase 2b study of PTI-125 for use in treating Alzheimer' disease. More >

Virtual Healthcare Tech Firm Reports Q3 FY20 Revenue Up 359% YOY
Source: Streetwise Reports  (6/1/20)
Demand for Reliq Health Technologies' offerings continues to grow due to the COVID-19 pandemic. More >

Myovant Sciences Shares Rise on NDA Filing for Uterine Fibroid Combination Therapy Drug
Source: Streetwise Reports  (6/1/20)
Shares of Myovant Sciences traded 40% higher after the company reported that it has submitted a New Drug Application to the FDA for once-daily relugolix combination tablet for the treatment of women with uterine fibroids. More >

AI Firm Develops Tool That Helps Radiologists Diagnose COVID-19
Source: Streetwise Reports  (5/30/20)
Patriot One Technologies and its partners have created a model that automatically calculates, from a radiological scan, the degree of a patient's affected lungs, a COVID-19 indicator. More >

Small-Cap Pharma Fast-Tracking Repurposed Drug for Covid-19
Source: Streetwise Reports  (5/27/20)
Algernon Pharmaceuticals is quickly moving ahead with a multinational Phase 2b/3 trial for Ifenprodil. More >

Surgical Equipment Firm Delivers Innovative Imaging Systems to Leading Urologists
Source: Streetwise Reports  (5/27/20)
Imagin Medical delivered two functional i/Blueâ„¢ Imaging Systems for use in conducting in vivo studies and virtual demonstrations for evaluation by leading urologists. More >

Biotech's 'Multiple Sclerosis Therapy Shows Improvement in Disability'
Source: Streetwise Reports  (5/27/20)
Atara Biotherapeutics' clinical trial design and results are reviewed in a ROTH Capital Partners report. More >

Biotech Identifies Antibody with 100% SARS-CoV-2 Inhibition
Source: Streetwise Reports  (5/27/20)
The goal of Sorrento Therapeutics to develop a Covid-19 antibody cocktail, including its progress, next steps and market opportunity, is reviewed in a Dawson James report. More >

Mersana Therapeutics Trades 60% Higher on Positive Phase 1 Ovarian Cancer Trial Data
Source: Streetwise Reports  (5/27/20)
Shares of Mersana Therapeutics reached a new 52-week high price after the company reported positive interim data from the expanded portion of its Phase 1 study of XMT-1536 for treatment of ovarian cancer. More >

Novavax Shares Rise 9% Upon Initiating Phase 1/2 COVID-19 Vaccine Clinical Trial
Source: Streetwise Reports  (5/26/20)
Novavax shares traded higher after the company reported it enrolled the first participants in its Phase 1 clinical study of NVX CoV2373. More >

Vertically Integrated Hemp/CBD Player Sweet Earth Holdings Debuts on CSE
Source: Peter Epstein for Streetwise Reports  (5/26/20)
With CBD showing some promise against Covid-19 and cannabis stocks rising, Peter Epstein of Epstein Research discusses the market with Sweet Earth Holdings executives. More >

Positive Test Results in Dairy Cows Lead to Upsized Livestock Supplement Order
Source: Streetwise Reports  (5/21/20)
With this sale, Avivagen's antibiotics-free, immune-boosting feed additive enters the Mexican market. More >

Biotech Partnership to Develop Diagnostic Assay for Alzheimer's Disease
Source: Streetwise Reports  (5/20/20)
With its work on this and a SARS-CoV-2 test, ProMIS Neurosciences is applying its technology platform in new ways. More >

Surface Oncology Shares Trade Up 40% on Phase 1 Study Plans for SRF617 Combined with Merck's KEYTRUDA
Source: Streetwise Reports  (5/20/20)
Shares of Surface Oncology set a new 52-week high price after the company reported that it is partnering with Merck & Co. in an immuno-oncology study of SRF617, targeting CD39 in combination with KEYTRUDA® (pembrolizumab) in solid tumor patients. More >

US Biopharma to Launch Phase 3 Trial in Bacterial Vaginosis
Source: Streetwise Reports  (5/20/20)
Daré Bioscience's study, its prospects and the indication's U.S. market opportunity are discussed in a ROTH Capital Partners report. More >

Arbutus Biopharma Trades 25% Higher on Phase 1 Hepatitis B Results
Source: Streetwise Reports  (5/19/20)
Shares of Arbutus Biopharma traded higher after the company reported significant and continuous reduction in HBsAg in 12 chronic hepatitis B subjects using 60 mg dosage of its AB-729 drug. More >

Surgical Imaging Company Provides Update on COVID-19 Impact
Source: Streetwise Reports  (5/18/20)
Imagin Medical reported that its actions have mitigated the impact of the coronavirus on its business operations. More >

Moderna Shares Rise 25% on Positive Phase 1 Coronavirus Vaccine Trial Data
Source: Streetwise Reports  (5/18/20)
Shares of Moderna Inc. traded higher, setting a new 52-week high price, after the firm reported positive interim results in its Phase 1 study of mRNA Vaccine (mRNA-1273) against SARS-CoV-2. More >

Biopharma Seeks Ethics Approval in Australia to Test COVID-19 Treatment
Source: Streetwise Reports  (5/18/20)
Algernon Pharmaceuticals intends to test a repurposed drug for this indication, in a trial in three countries. More >

Cannabis Cultivator Shifts Focus to Commercializing Technology
Source: Streetwise Reports  (5/18/20)
Sproutly Canada has received capital investment from Infusion Biosciences. More >